Dow Up 0.07% Nasdaq Up 0.61%

Lpath Inc. (LPTN)

-NasdaqCM
2.57 Down 0.08(3.02%) Nov 26, 4:00PM EST
Prev Close:2.65
Open:2.59
Bid:2.54 x 600
Ask:N/A
1y Target Est:14.00
Beta:-0.44
Next Earnings Date:N/A
Day's Range:2.56 - 2.69
52wk Range:2.45 - 5.30
Volume:25,251
Avg Vol (3m):28,532
Market Cap:49.54M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):64.25
P/S (ttm):7.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Dec-14) :-0.34
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback